EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles

Peter Ruzanov, Valentina Evdokimova, Manideep C Pachva, Alon Minkovich, Zhenbo Zhang, Sofya Langman, Hendrik Gassmann, Uwe Thiel, Marija Orlic-Milacic, Syed H Zaidi, Vanya Peltekova, Lawrence E Heisler und 11 weitere

Journal of Clinical Investigation · 01.05.2024 · 134 (9)

DOI: 10.1172/jci169470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 26.03.2024. Verfasst von Peter Ruzanov und 22 weiteren Autor:innen. Beteiligte Einrichtung: Ontario Institute for Cancer Research, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, DNA Damage, Oncogene Proteins, Fusion, Transcriptional Regulator ERG. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Goverment of Ontario, Cura Placida Children’s Cancer Research Foundation grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant expression of the E26 transformation-specific (ETS) transcription factors characterizes numerous human malignancies. Many of these proteins, including EWS:FLI1 and EWS:ERG fusions in Ewing sarcoma (EwS) and TMPRSS2:ERG in prostate cancer (PCa), drive oncogenic programs via binding to GGAA repeats. We report here that both EWS:FLI1 and ERG bind and transcriptionally activate GGAA-rich pericentromeric heterochromatin. The respective pathogen-like HSAT2 and HSAT3 RNAs, together with LINE , SINE , ERV, and other repeat transcripts, are expressed in EwS and PCa tumors, secreted in extracellular vesicles (EVs), and are highly elevated in plasma of patients with EwS with metastatic disease. High human satellite 2 and 3 ( HSAT2,3 ) levels in EWS:FLI1- or ERG-expressing cells and tumors were associated with induction of G2/M checkpoint, mitotic spindle, and DNA damage programs. These programs were also activated in EwS EV-treated fibroblasts, coincident with accumulation of HSAT2,3 RNAs, proinflammatory responses, mitotic defects, and senescence. Mechanistically, HSAT2,3 -enriched cancer EVs induced cGAS-TBK1 innate immune signaling and formation of cytosolic granules positive for double-strand RNAs, RNA-DNA, and cGAS. Hence, aberrantly expressed ETS proteins derepress pericentromeric heterochromatin, yielding pathogenic RNAs that transmit genotoxic stress and inflammation to local and distant sites. Monitoring HSAT2,3 plasma levels and preventing their dissemination may thus improve therapeutic strategies and blood-based diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDNA DamageOncogene Proteins, FusionTranscriptional Regulator ERGRNA-Binding Protein EWSProto-Oncogene Protein c-fli-1HumansMaleSarcoma, EwingCell Line, TumorRNA, NeoplasmInflammationProstatic NeoplasmsMiceAnimalsHeterochromatin

Stichwörter der Autor:innen

InflammationInnate immunity

Substanzen

Oncogene Proteins, FusionTranscriptional Regulator ERGRNA-Binding Protein EWSERG protein, humanProto-Oncogene Protein c-fli-1RNA, NeoplasmEWS-FLI fusion proteinHeterochromatin

Autor:innen und Institutionen

  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Department of Molecular Oncology, British Columbia Cancer Research Centre and.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada.
  • STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Förderung

  • CIHR
  • Goverment of Ontario, Cura Placida Children’s Cancer Research Foundation grants

Zitieren

APA

Ruzanov, P., Evdokimova, V., Pachva, M. C., Minkovich, A., Zhang, Z., Langman, S., Gassmann, H., Thiel, U., Orlic-Milacic, M., Zaidi, S. H., Peltekova, V., Heisler, L. E., Sharma, M., Cox, M. E., McKee, T. D., Zaidi, M., Lapouble, E., McPherson, J. D., Delattre, O., …, & Sorensen, P. H. (2024). Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles. Journal of Clinical Investigation, 134(9). https://doi.org/10.1172/jci169470

Vancouver

Ruzanov P, Evdokimova V, Pachva MC, Minkovich A, Zhang Z, Langman S, et al. Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles. Journal of Clinical Investigation. 2024;134(9). doi:10.1172/jci169470

BibTeX
@article{Ruzanov2024,
  author = {Ruzanov, Peter and Evdokimova, Valentina and Pachva, Manideep C and Minkovich, Alon and Zhang, Zhenbo and Langman, Sofya and Gassmann, Hendrik and Thiel, Uwe and Orlic-Milacic, Marija and Zaidi, Syed H and Peltekova, Vanya and Heisler, Lawrence E and Sharma, Manju and Cox, Michael E and McKee, Trevor D and Zaidi, Mark and Lapouble, Eve and McPherson, John D and Delattre, Olivier and Radvanyi, Laszlo and Burdach, Stefan Eg and Stein, Lincoln D and Sorensen, Poul H},
  title = {Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {9},
  doi = {10.1172/jci169470}
}
Kostenlos starten →